It feels like we’re in the eye of the M&A storm – somewhere between the big deals announced in August, September and October, and the next batch of pre-Christmas craziness.
It was a breakthrough announcement for Woodside, and one of three we’re expecting in the coming four weeks or so that will have a lasting impact on Australia’s oil and gas major.
Otherwise, it was pretty quiet for a Monday. Link said it would allow The Carlyle Group to conduct due diligence, avoiding an investor revolt, and Ventia was out with its underwritten downsized IPO as we covered on Saturday.
In Street Talk tomorrow, we look at Aussie biotech Ellume, which is on every equity capital market banker’s watchlist. Ellume’s in the market with a chunky pre-IPO raising that values it at more than $500 million.
The thermal plasma and modular processing plant specialist is raising $25 million, with the expectation of listing with a $120 million market capitalisation.
